BPC-157 + KPV + Selank + Larazotide Gut-Brain Axis Stack

There is no validated protocol; these are research compounds and the combination is untested clinically. Representative community approaches: BPC-157 250–500 mcg subcutaneously (or oral capsules some use for luminal gut effects) once or twice daily during defined 4–6 week runs; KPV around 250–500 mcg subcutaneously or orally as an anti-inflammatory tripeptide, often cycled similarly; Larazotide is an oral tight-junction regulator studied in celiac disease and would only make mechanistic sense taken orally before meals; Selank is typically used as an intranasal spray at roughly 250–500 mcg per dose for its anxiolytic and nootropic profile. Introduce one peptide at a time so you can attribute any response or side effect. Any short cycle should be paired with the dietary and medical fundamentals that actually drive gut-brain health. Because doses and product quality vary widely, this is experimental self-experimentation, not a clinician-endorsed regimen.